Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.920
0.00 (0.00%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Boundless Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -57.72 | -49.43 | -45.9 | -25.21 |
Depreciation & Amortization | 1.01 | 0.96 | 0.94 | 0.68 |
Loss (Gain) From Sale of Investments | -5.16 | -3.3 | 0.5 | 0.54 |
Stock-Based Compensation | 5.26 | 3.34 | 2.29 | 1.16 |
Other Operating Activities | 2.54 | 2.39 | 1.7 | 0.42 |
Change in Accounts Payable | 2.44 | 1.66 | 1.91 | 1.22 |
Change in Other Net Operating Assets | -4.25 | -2.46 | -1.05 | -2.06 |
Operating Cash Flow | -55.89 | -46.86 | -39.6 | -23.25 |
Capital Expenditures | -2.01 | -0.63 | -1.07 | -2.03 |
Investment in Securities | -39.95 | -37.63 | 17.2 | -57.25 |
Investing Cash Flow | -41.96 | -38.26 | 16.13 | -59.29 |
Issuance of Common Stock | 93.18 | 0.18 | 0.13 | 0.21 |
Other Financing Activities | -4.96 | -1.96 | - | - |
Financing Cash Flow | 87.89 | 97.9 | 0.13 | 105.53 |
Net Cash Flow | -9.95 | 12.78 | -23.34 | 22.99 |
Free Cash Flow | -57.89 | -47.49 | -40.66 | -25.28 |
Free Cash Flow Per Share | -8.99 | -39.05 | -37.04 | -29.38 |
Levered Free Cash Flow | -36.04 | -30.95 | -24.76 | - |
Unlevered Free Cash Flow | -36.04 | -30.95 | -24.76 | - |
Change in Net Working Capital | -0.34 | 0.36 | -2.12 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.